Close Menu

NEW YORK (GenomeWeb) – Diagnostics firm MolecularMD has signed an exclusive agreement with clinical oncology laboratory Genoptix to market, distribute, and perform diagnostic testing services for the MRDx BCR-ABL companion diagnostic test.

Under the terms of the agreement, Genoptix will be the exclusive provider in the US of MRDx testing services and kits. Financial terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.